文献速递血液净化与透析肾移植

转为Medicare Advantage与保留传统Medicare的ESKD受益人比较

Comparing Medicare Fee-for-Service Beneficiaries with ESKD Who Switched to Medicare Advantage versus Remained in Traditional Medicare.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-07-16

该研究利用美国肾脏数据系统分析2021年从FFS转为Medicare Advantage的透析和肾移植患者特征。411513名FFS覆盖患者中10.1%转保,透析人群转保率12%,肾移植人群5%。黑种人、西班牙裔、双资格和南部居民转保几率更高,提示FFS数据代表性受限。

要点

  • 透析患者转保率12%,肾移植患者转保率5%,总体FFS患者转保率10.1%。
  • 黑种人和西班牙裔透析患者转保几率高于白种人,调整OR分别为1.69和1.42。
  • 南部居民转保几率高于西部,调整OR为1.48;双资格患者OR为1.12。

核心结论

  • 从FFS转为Medicare Advantage的患者不成比例地来自历史上被边缘化的群体,包括黑种人、西班牙裔和低收入个体,且更可能居住在南部。
  • 这些差异可能威胁依赖FFS保险索赔的美国肾脏数据系统数据的普遍性,并提示比较FFS与Medicare Advantage受益人结局时应调整关键患者特征。

研究设计与样本

  • 使用美国肾脏数据系统数据,比较2021年从FFS转为Medicare Advantage与留在FFS的透析患者和肾移植受者的特征。
  • 2020年有FFS覆盖的411513名患者中,10.1%在2021年转为Medicare Advantage。
  • 采用未调整和调整逻辑回归比较人口学和地理亚组的转保比值比。

主要发现

  • 转保者占透析人群的12%,占肾移植人群的5%。
  • 透析人群中,黑种人转保调整OR为1.69(95%CI 1.64-1.73),西班牙裔调整OR为1.42(95%CI 1.40-1.47),均高于白种人。
  • 双资格医疗补助者调整OR为1.12(95%CI 1.09-1.15);南部居民调整OR为1.48(95%CI 1.43-1.52),均高于西部居民。
  • 肾移植受者中观察到类似差异。

临床怎么用

  • 解读基于FFS索赔的美国肾脏数据系统数据时需考虑转保带来的选择偏倚。
  • 比较FFS与Medicare Advantage受益人结局时应调整种族、民族、社会经济地位和地理区域等关键特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients choosing Medicare Advantage versus Medicare fee-for-service (FFS) differ with respect to race, socioeconomic status, and burden of disease. However, it is unclear whether these differences also occur among patients with kidney failure, who were newly allowed to switch to Medicare Advantage after the 21st Century Cares Act. We used data from the United States Renal Data System to examine differences in characteristics of dialysis patients and kidney transplant recipients who switched from FFS to Medicare Advantage compared with those who stayed with FFS in 2021, the first year such switching was allowed. We used unadjusted and adjusted logistic regression to compare odds of switching among demographic and geographic subgroups. Among 411,513 patients with FFS coverage in 2020, 10.1% switched to Medicare Advantage in 2021. Switchers constituted 12% of the dialysis population and 5% of the kidney transplant population. In the dialysis population, patients of Black race and Hispanic ethnicity were more likely to switch than patients of White race (adjusted odds ratio [OR], 1.69; 95% confidence interval [CI], 1.64 to 1.73 and OR, 1.42; 95% CI, 1.40 to 1.47; respectively), as were patients with dual eligibility for Medicaid (adjusted OR, 1.12; 95% CI, 1.09 to 1.15). Patients living in the South were also more likely to switch to Medicare Advantage than those living in the West (adjusted OR, 1.48; 95% CI, 1.43 to 1.52). Similar differences were observed among kidney transplant recipients. Patients who switched from FFS to Medicare Advantage were disproportionately from historically marginalized groups, including Black, Hispanic, and low-income individuals. They were also more likely to live in the South. These differences may threaten the generalizability of United States Renal Data System data that relies on FFS insurance claims and suggest that comparisons of outcomes between FFS and medicare advantage beneficiaries with kidney failure should be adjusted for key patient characteristics.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Gao AY, Knapp CD, Liu J, et al. Comparing Medicare Fee-for-Service Beneficiaries with ESKD Who Switched to Medicare Advantage versus Remained in Traditional Medicare. Clin J Am Soc Nephrol. 2024. PMID: 39012709. doi:10.2215/CJN.0000000000000512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。